DP

Dhiraj Pandurang Gore

Director Director DIN 07040166
DIN 07040166 First appointment Feb 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2015
Shareholding value •••• Premium profile

About Dhiraj Pandurang Gore

Data last updated:

Dhiraj Pandurang Gore was a Director at Fidelity Life Sciences Private Limited (2015–2019) and Director at Synapse Labs Private Limited (2015–2016). The companies operate in Pharma.

DIN 07040166
Primary Designation Director
Industry Pharma
First Appointment 25 Feb 2015

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Mar 20152010₹10.18 Cr (FY 2025)Active
Synapse Labs Private Limited U24233PN2007PTC129504
Director25 Feb 20152007₹20.63 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Fidelity Life Sciences Private Limited
Synapse Labs Private Limited
Premium access

Shareholding and investment profile for Dhiraj Pandurang Gore

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhiraj Pandurang Gore

Dhiraj Pandurang Gore was first appointed on 25 Feb 2015 as Director at Synapse Labs Private Limited.

Dhiraj Pandurang Gore held 2 earlier board appointments: Fidelity Life Sciences Private Limited (Director, 02 Mar 2015 to 01 Apr 2019); Synapse Labs Private Limited (Director, 25 Feb 2015 to 31 Aug 2016).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available